Clinical Trial Update: A Phase III Study of the Efficacy and Safety of Olokizumab in Patients With Polymyalgia Rheumatica [Phase 3]

View source ↗

Summary

Phase III trial evaluating the efficacy and safety of olokizumab in polymyalgia rheumatica is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• Olokizumab (olokizumab)

Snippet

Sponsor: R-Pharm International, LLC | Conditions: Polymyalgia Rheumatica | Phase 3 | Status: ACTIVE_NOT_RECRUITING